| 000 | 01747 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515003646.0 | ||
| 264 | 0 | _c20051223 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a0741-238X | ||
| 024 | 7 |
_a10.1007/BF02849935 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFuenfstueck, R | |
| 245 | 0 | 0 |
_aEfficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers. _h[electronic resource] |
| 260 |
_bAdvances in therapy _c |
||
| 300 |
_a263-77 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadministration & dosage |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzoates _xadministration & dosage |
| 650 | 0 | 4 | _aBiphenyl Compounds |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrochlorothiazide _xadministration & dosage |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTelmisartan |
| 650 | 0 | 4 |
_aTetrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aValine _xadministration & dosage |
| 650 | 0 | 4 | _aValsartan |
| 700 | 1 | _aHempel, R-D | |
| 700 | 1 | _aAnsari, A | |
| 700 | 1 | _aWeidinger, G | |
| 700 | 1 | _aKlebs, S | |
| 773 | 0 |
_tAdvances in therapy _gvol. 22 _gno. 3 _gp. 263-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02849935 _zAvailable from publisher's website |
| 999 |
_c15864694 _d15864694 |
||